School of Medicine


Showing 1-10 of 18 Results

  • Guido A. Davidzon

    Guido A. Davidzon

    Clinical Associate Professor, Radiology - Rad/Nuclear Medicine

    BioDr. Guido A. Davidzon is a physician-scientist board-certified in Nuclear Medicine. He is an attending physician in Nuclear Medicine and Molecular Imaging at Stanford Health Care. He graduated with honors from medical school in Argentina and completed an internship at Yale University New-Haven Hospital in Connecticut. He did his residency and was chief resident at Stanford Health Care. He completed a U.S. National Library of Medicine-supported Biomedical Informatics fellowship at Massachusetts General Hospital with a Science Master at MIT.

    Dr. Davidzon is a Clinical Associate Professor in the Department of Radiology at Stanford University. His clinical specialties include molecular probe-based early diagnostic imaging of cancer, coronary artery disease, and dementia, as well as targeted radiopharmaceutical therapy for cancer treatment.

    Dr. Davidzon is the Cardiac PET and SPECT program director and the acting Chair of the Radioactive Drug Research and Clinical Radiation Safety Committees. Guido steers clinical efforts in using PET to evaluate cognitive disorders and assess treatment response for patients receiving novel anti-amyloid therapies. He is an active member of the Artificial Intelligence Task Force at the SNMMI and leads research and translational efforts in artificial intelligence and nuclear medicine at Stanford. Dr. Davidzon is the immediate past President of the Northern California Chapter of the SNMMI.

  • Benjamin Lewis Franc

    Benjamin Lewis Franc

    Clinical Professor, Radiology - Rad/Nuclear Medicine

    BioDr. Franc is a Clinical Professor of Radiology - Nuclear Medicine and Molecular Imaging. He completed his B.S and M.S. in Chemical Engineering at Stanford University, Stanford, CA. He completed his medical school training at University of Southern California, Keck School of Medicine. While conducting his residency at Stanford University, in the Division of Nuclear Medicine and Molecular Imaging, he was also the chief resident. Dr. Franc’s research interests include all aspects of PET-CT as he has nearly 20 years of experience in clinical Nuclear Medicine with particular expertise in PET-CT.

    Dr. Franc predominantly publishes and lectures on applications and innovations of PET-CT. He has proficiency in all aspects of PET radiopharmaceutical development, spanning the design of molecules, synthesis of radioligands, and use in animal and human imaging. He also has expertise in quantitative image analysis, development of novel post-processing image reconstruction methods, and the application of artificial intelligence in human diagnostics. Dr. Franc has implemented new radiopharmaceuticals in pre-clinical and clinical research PET imaging as well as for clinical PET with applications in cancer, infectious disease (HIV), and autoimmune disease (RA). He has applied advanced computational techniques, including deep learning, to extract predictive data for prognosis of various cancers and neurodegenerative diseases from molecular imaging modalities.

    Since joining the faculty at Stanford in 2018, Dr. Franc has received several awards including the Radiological Society of North America 2019 Margulis Award for Excellence in Research; RSNA 2019 Trainee Research; and Most read article in Radiology 2019. He has accepted the position of Director, Residency Program, Nuclear Medicine and Molecular Imaging as well as the Director, Radiology Value-Based Care Initiative. Dr. Franc has presented more than 40 abstracts at national and international meetings and published more than 90 papers in peer-reviewed publications, as well as 9 book chapters.

  • Erin Elizabeth Grady

    Erin Elizabeth Grady

    Clinical Professor, Radiology - Rad/Nuclear Medicine

    BioErin Grady, MD, CCD, FACNM, FSNMMI is a nuclear medicine physician at Stanford Hospital and Clinics in Stanford, California. She is actively involved nationally in the SNMMI in multiple capacities including as a Director-at-Large on the SNMMI Board of Directors, chair of the Nuclear Medicine Program Directors, a member of the General Nuclear Medicine Council board, co-chair of the Government Relations Committee and a longstanding member of the Coding and Reimbursement Committee. In addition, she is a past chair of the American Board of Nuclear Medicine and has served on the board of appeals panel, review committee and milestone development committee for Nuclear Medicine and milestone revision committee for Nuclear Radiology at the ACGME. Her areas of research interest include quality, education, radiopharmaceutical therapy and finding answers to clinical questions that arise during the course of practice. She is passionate about education in nuclear medicine, nuclear medicine’s future and is a staunch advocate for patients.

  • Kip E. Guja, MD PhD

    Kip E. Guja, MD PhD

    Clinical Instructor, Radiology - Rad/Nuclear Medicine

    Current Research and Scholarly InterestsMy current research interests include:
    1) PET/MR and PET/CT imaging in children and adults, for oncologic and non-oncologic indications
    2) Targeted radionuclide therapy and theragnostics
    3) Pre-clinical development and clinical translation of novel radiopharmaceuticals

  • Kristina Elizabeth Hawk

    Kristina Elizabeth Hawk

    Clinical Assistant Professor, Radiology - Rad/Nuclear Medicine

    BioKristina Elizabeth Hawk, MS MD PhD is a Nuclear Medicine Physician and Neuroradiologist. As a physician scientist, integrated MD/PhD training helped build a foundation to explore translational research efforts, using a full and intricate understanding of the research process, and the developed ability to understand, discuss and teach new emerging concepts. Dr. Hawk’s dissertation in Neuroscience focused on the regulation of Nitric Oxide Synthase in the dorsal and ventral striatum, exploring the neurochemical role of nitric oxide producing interneurons, and their ability to coordinate dopaminergic and glutamatergic signaling in areas of the brain relevant to cognition and motivated behavior.

    Eager to expand her passion into the field of Medical Radiation Physics, she also completed a separate Masters degree in Medical Radiation Physics. This provided her with in depth training of how therapeutic and diagnostic instruments use both ionizing and non-ionizing radiation in the clinical setting. She then completed her Medical Doctorate and Diagnostic Radiology Residency at the University of Southern California (USC), learning the art of medicine while serving the diverse population at Los Angeles County Hospital.

    Dr. Hawk completed clinical fellowship requirements in Nuclear Medicine at USC, and is now Board Certified by the American Board of Nuclear Medicine. She also completed a Neuroradiology fellowship at USC, and is Board Certified the American Board of Radiology. She served as both the Chief Resident and Chief Neuroradiology Fellow.

    Dr. Hawk has held multiple local and national leadership positions, including positions in the American College of Radiology (ACR), the American College of Nuclear Medicine (ACNM) and the Society of Nuclear and Molecular Medicine (SNMMI). Dr. Hawk is an editorial board member of the Journal of the American College of Radiology (JACR). She has served as the Vice-Chair for Education for the Nuclear Medicine Resident Organization of the ACNM, and the Educational Liaison for the Resident and Fellow Section of the ACR. Currently, she serves on the national ACR Commission for Women and General Diversity as well as the ACR Commission on Nuclear Medicine. Dr. Hawk also sits on the ACR Council Steering Committee.

    Dr. Hawk is committed to continually exploring the beautiful applications of ionizing and non-ionizing radiation to image and treat the human body.

  • Andrei Iagaru

    Andrei Iagaru

    Professor of Radiology (Nuclear Medicine)
    On Leave from 08/05/2024 To 12/13/2024

    Current Research and Scholarly InterestsCurrent research projects include:
    1) PET/MRI and PET/CT for Early Cancer Detection
    2) Targeted Radionuclide Therapy
    3) Clinical Translation of Novel PET Radiopharmaceuticals;